Call us at (800) 421-8453
Donate
  • Contact Us
  • Clinical Trial Finder
  • About Us
    • Who We Are & What We Do
    • Mission & Vision
    • History
    • National Staff
    • Board Members
    • MARAC Advisories
    • Financials and Accountability
    • Job Openings
    • 2023-2024 Impact Report
    • Brochures
      • Who We Are and What We Do
      • Gene Therapy
      • CHW Education and Training
  • Sickle Cell Disease
    • Definition
      • What is Sickle Cell Disease (SCD)?
      • What is Sickle Cell Trait (SCT)?
      • Complications & Treatments
      • Glossary
      • FAQs
    • Links & Resources
    • Get Connected
    • oneSCDVoice
    • Our Stories
    • COVID-19
      • Information and Resources
      • Template Letters
  • Gene Therapy
    • SCDAA Statement on Approval
    • Warrior FAQs
  • Clinical Trials
    • Clinical Trials 101
    • Clinical Trial Finder
    • SCD C.A.R.E.S. Consortium
  • Our Initiatives
    • SCDAA and MedicAlert Pilot Program
    • Clinical Trial Finder
    • Mental Health and Wellness
    • Community Health Worker Training
    • The P.O.W.E.R. ECHO Project
    • Leadership Academy
    • Donate Blood for Sickle Cell
    • National Sickle Cell Advocacy Network
    • Volunteer
  • Advocacy
    • Advocacy Days
    • Advocacy Resources
    • Ambassadors & Celebrity Champions
      • Ayana Johnson
      • Markus Golden
      • Dexter Darden
      • London Knight
      • Howard Woolley
    • Find Your Representative
    • Congressional Sickle Cell Caucus
    • National Sickle Cell Advocacy Network
  • Events
    • World Sickle Cell Day
    • Sickletini Happy Hour
    • SCDAA Warrior Walkathon
    • National Sickle Cell Awareness Month
    • Annual National Convention
      • Abstract Competition
    • P.O.W.E.R. ECHO Trainings
    • Masterclass
  • News
    • SCDAA in the Press
    • Sickle Cell News
    • Media Partnerships
      • HCPLive®
      • EBONY
      • EMERGE Woman Magazine
      • MONARCH Magazine
      • BLACKDOCTOR.ORG
  • Membership
    • Find Member Organizations
    • Become A Member Organization
    • Member Benefits
  • Donate
    • Donate Now
    • 50 Years Forward
    • Legacy Donation
    • Workplace Giving
    • Give from a Donor-Advised Fund
    • Give from an IRA
    • Give Cryptocurrency

Blog

MARAC Statement: Health Insurance Coverage for MSD SCT

  • September 22, 2023
  • Emma Day

MARAC Statement: Health Insurance Coverage for Hematopoietic Stem Cell Transplant for Sickle Cell Disease from HLA-matched Sibling Donor (MSD HCT) Sept.... Continue Reading

MARAC Statement: Update About COVID

  • September 22, 2023
  • Emma Day

Sept. 16, 2023 – The worldwide pandemic of COVID-19 (SARS-CoV2) infections seem to have settled down, and we are now seeing... Continue Reading

SCDAA and MedicAlert Foundation Launch Pilot Program

  • September 21, 2023
  • Emma Day

Leading Sickle Cell Organization and MedicAlert Foundation Launch Pilot Program to Improve Emergency Care During Sickle Cell Pain Crises Non-profits partner to... Continue Reading

Sickle Cell Awareness Month 2023 Events

  • August 28, 2023
  • Emma Day

All across the country, our member organizations are hosting exciting events for Sickle Cell Awareness Month this September. Check out the... Continue Reading

Abstracts Accepted Until 11:59 p.m. PST

  • July 17, 2023
  • Emma Day

This morning, we were notified that some users experienced issues using our 2023 National Abstract Competition portal. This issue has been... Continue Reading

MARAC Statement: Crizanlizumab (Adakveo)

  • July 7, 2023
  • Emma Day

July 7, 2023 – SCDAA’s Medical and Research Advisory Committee (MARAC) notes that the European Medicines Agency’s (EMA) Committee for Medicinal... Continue Reading

SCDAA Teams with MedicAlert Foundation

  • June 26, 2023
  • Emma Day

Sickle Cell Disease Association of America Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises Nonprofits partner to... Continue Reading

Afimmune joins the SCD C.A.R.E.S. Consortium

  • June 19, 2023
  • Emma Day

Dublin, Ireland, 19 June 2023: Afimmune, a clinical stage biopharmaceutical company developing novel rare disease therapeutics, today announced it has been invited to... Continue Reading

CMO Speaks: Gene Therapy for SCD (Part 1)

  • June 2, 2023
  • Emma Day

CMO Speaks is a blog featuring the voices of SCDAA’s clinical leadership team. Part 1 of our Gene Therapy series was... Continue Reading

SCDAA Announces FY24 Legislative Priorities

  • May 1, 2023
  • Emma Day

Did you know that the federal government is poised to make some of the biggest decisions in sickle cell history right... Continue Reading

  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 13
  • 14
  • 15
  • →

CATEGORIES

  • CMO Speaks
  • MARAC Statements
  • News
  • Uncategorized

Archives

Sickle Cell Disease Association of America Inc. Seal of Transparency

Quick Links

  • About Us
  • Donate
  • Newsroom
  • Events
  • Membership
  • Initiatives
  • Site Map
  • Disclaimer
  • Privacy

Sign up for updates!

Get news from Sickle Cell Disease Association of America in your inbox.

Terms and conditions

Contact Us

Address:
7240 Parkway Drive, Suite 180
Hanover, MD 21076

Phone:
410.528.1555 (office)
410.528.1495 (fax)
800.421.8453 (toll-free)

Email:
info@sicklecelldisease.org

Copyright ©2021 Sickle Cell Disease Association of America, Inc - All rights reserved.